Search results
Allergy-immunology specialists Dang and Patel named 2024 Castle Connolly Top Doctors
Digital Journal· 11 hours ago24-7 Press ReleaseAndrew T. Dang, MD, and Gital K. Patel, MD, have been recognized as 2024 Castle Connolly Top Doctors — the first year for both to receive the prestigious Top Doctor honor.
Health officials keep eye on ‘FLiRT’ COVID variants that could lead to fall surge
Maryland Matters via Yahoo News· 8 hours agoWith Maryland nearing 1.5 million reported cases of COVID-19 since the start of the pandemic,...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 2 hours agoLouis. Still, "if I'm a patient and I've failed all other kinds of therapies and someone offers me a...
Why Novartis (NVS) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 4 hours agoIt continues to build depth in core therapeutic areas like cardiovascular, renal and metabolic, ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 12 hours agoJune 4, 2024Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune ...
Genetic changes identified as key to childhood lupus
Medical Xpress· 21 hours agoIn people with lupus the body's immune system mistakenly attacks its own cells and tissues. Until now, its exact cause has been unknown, but it was thought to be a combination of genetic and ...
Merck KGaA taps AI-focused biotech for new ADC pact worth $376M
FierceBiotech· 4 hours agoMerck KGaA is hoping to sprout some new oncology and immunology therapeutics with Biolojic Design’s AI-driven drug discovery engine. Merck has signed the multitarget drug ...
Doctor explains why yellow-green pollen that’s all over Mass. likely isn’t triggering allergies
WCVB Boston· 17 hours agoPeople in Massachusetts have likely noticed a lot of yellow-green dust on outdoor objects lately,...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 23 hours agoCOVID-19 was “a brand-new virus, so it opened the way to apply these newer methods,” an immunology...
Phase III trial shows donidalorsen cuts attack rate in hereditary angioedema
Medical Xpress· 5 hours agoFor patients with hereditary angioedema, donidalorsen reduces the attack rate, according to a study...